Dr. Hans-Josef Ritzert to Head Evonik's Chinese Business
Evonik has appointed Dr. Hans-Josef Ritzert as its regional president of greater China, effective Sept. 1. Ritzert currently heads the company's Exclusive Synthesis & Pharma Amino Acids business and was previously head of its Catalysts business. Evonik has about 3500 employees in the greater China region and had a turnover exceeding €1 billion in 2010. Ritzert, who holds a doctorate in chemistry, takes over the position from Dr. Dahai Yu, who was appointed to Evonik's executive board in April.
Dr. Jean-Luc Herbeaux will head the newly formed Health Care business line. Herbeaux, who has been leading the company's Pharma Polymers business since the beginning of 2009, joined Evonik Industries (then Degussa) in 2000.
most read
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Oxea Returns to its Roots
Oxea is returning to its old name and its roots.
Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.